Singapore markets closed
  • Straits Times Index

    +6.02 (+0.18%)
  • Nikkei

    -36.55 (-0.09%)
  • Hang Seng

    -306.80 (-1.67%)
  • FTSE 100

    -34.74 (-0.42%)
  • Bitcoin USD

    +110.80 (+0.17%)
  • CMC Crypto 200

    -8.59 (-0.63%)
  • S&P 500

    -8.55 (-0.16%)
  • Dow

    +15.57 (+0.04%)
  • Nasdaq

    -32.23 (-0.18%)
  • Gold

    -34.30 (-1.45%)
  • Crude Oil

    -0.70 (-0.86%)
  • 10-Yr Bond

    +0.0030 (+0.07%)
  • FTSE Bursa Malaysia

    -2.32 (-0.15%)
  • Jakarta Composite Index

    +60.66 (+0.89%)
  • PSE Index

    -186.08 (-2.93%)

Swedish Exchange Showcases Three Growth Companies With High Insider Ownership

As global markets show signs of stabilization with moderated inflation rates and shifting interest rate expectations, Sweden's stock exchange offers a unique perspective with several growth companies characterized by high insider ownership. This attribute often signals strong confidence in the company's future from those who know it best, aligning well with current market conditions that favor informed, strategic investment decisions.

Top 10 Growth Companies With High Insider Ownership In Sweden


Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)



Spago Nanomedical (OM:SPAGO)



BioArctic (OM:BIOA B)



Calliditas Therapeutics (OM:CALTX)



InCoax Networks (OM:INCOAX)






Egetis Therapeutics (OM:EGTX)



Yubico (OM:YUBICO)



SaveLend Group (OM:YIELD)



OrganoClick (OM:ORGC)



Click here to see the full list of 84 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.


Here's a peek at a few of the choices from the screener.


Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) focuses on developing biological drugs for central nervous system disorders in Sweden, with a market capitalization of approximately SEK 20.70 billion.

Operations: The company generates its revenue primarily from the development of biological drugs targeting central nervous system disorders.

Insider Ownership: 35.1%

Earnings Growth Forecast: 63.5% p.a.

BioArctic, a Swedish biotech firm, has seen a significant shift in financial performance with recent Q1 earnings showing a drop in sales to SEK 29.64 million from SEK 393.43 million the previous year and transitioning from net income to a loss of SEK 57.56 million. Despite these challenges, the company is optimistic about its future growth potential, particularly through strategic alliances like the recent one with Eisai Co., aimed at developing Alzheimer's treatments using BioArctic’s BrainTransporter™ technology. Analysts expect BioArctic's revenue to grow by 48.1% annually and project it will become profitable within three years, suggesting robust future prospects despite current volatility.

OM:BIOA B Earnings and Revenue Growth as at May 2024
OM:BIOA B Earnings and Revenue Growth as at May 2024


Simply Wall St Growth Rating: ★★★★★☆

Overview: Fortnox AB (publ) offers financial and administrative software solutions tailored for small and medium-sized businesses, accounting firms, and organizations, with a market capitalization of approximately SEK 42.79 billion.

Operations: Fortnox AB generates its revenue primarily through five segments: Core Products at SEK 698 million, The Agency at SEK 327 million, Entrepreneurship at SEK 356 million, Money at SEK 232 million, and Marketplaces at SEK 150 million.

Insider Ownership: 21%

Earnings Growth Forecast: 21.1% p.a.

Fortnox, a Swedish software company, reported strong Q1 2024 results with revenue rising to SEK 473 million and net income increasing to SEK 149 million. The firm is experiencing robust growth with earnings expected to rise by 21.11% annually over the next three years, outpacing the broader Swedish market's growth. Insider activities show more buying than selling in recent months, indicating confidence from those closest to the company. This aligns with a forecasted high Return on Equity of 33.2% in three years, suggesting efficient management and profitable operations.

OM:FNOX Ownership Breakdown as at May 2024
OM:FNOX Ownership Breakdown as at May 2024

AB Sagax

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AB Sagax (publ) is a property company active in Sweden, Finland, France, Benelux, Spain, Germany, and other European countries with a market capitalization of approximately SEK 103.57 billion.

Operations: The company generates its revenue primarily from real estate rentals, amounting to SEK 4.47 billion.

Insider Ownership: 28.3%

Earnings Growth Forecast: 33.8% p.a.

AB Sagax, a real estate firm in Sweden, has shown notable financial dynamics recently. In Q1 2024, it rebounded from a previous loss to report SEK 1.08 billion in net income with sales reaching SEK 1.19 billion. Despite this recovery, the company's debt is poorly covered by operating cash flow, indicating potential financial strain. Dividend affirmations and increases reflect confidence in sustaining shareholder returns. Expected earnings growth over the next three years is significantly higher than the market forecast, suggesting optimism about future profitability despite recent fiscal challenges.

OM:SAGA A Earnings and Revenue Growth as at May 2024
OM:SAGA A Earnings and Revenue Growth as at May 2024

Taking Advantage

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:BIOA B OM:FNOX and OM:SAGA A.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email